Cargando…

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease

The presence of circulating tumor cells (CTCs) in peripheral blood is associated with metastasis and prognosis in hepatocellular carcinoma (HCC) patients. The epithelial–mesenchymal transition (EMT) has a pivotal role in tumor invasion and dissemination. To identify more sensitive biomarkers for eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Y-M, Xu, S-C, Li, J, Han, K-Q, Pi, H-F, Zheng, L, Zuo, G-H, Huang, X-B, Li, H-Y, Zhao, H-Z, Yu, Z-P, Zhou, Z, Liang, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824657/ https://www.ncbi.nlm.nih.gov/pubmed/24091674 http://dx.doi.org/10.1038/cddis.2013.347

Ejemplares similares

Knockdown of BAG3 induces epithelial–mesenchymal transition in thyroid cancer cells through ZEB1 activation
por: Meng, X, et al.
Publicado: (2014)

DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis
por: Zhao, F, et al.
Publicado: (2015)

Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure
por: Wang, Y., et al.
Publicado: (2014)

Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis
por: Xu, Q, et al.
Publicado: (2016)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
por: Shi, Z-M, et al.
Publicado: (2017)

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1995)

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
por: Xie, G, et al.
Publicado: (2014)

Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial–mesenchymal transition in human hepatocellular carcinoma
por: Jia, R-J, et al.
Publicado: (2014)

Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5
por: Yu, Z., et al.
Publicado: (2017)

Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2021)

Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer
por: Fan, X-J, et al.
Publicado: (2012)

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
por: Xu, Rongzhong, et al.
Publicado: (2021)

LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer
por: Liu, Y-w, et al.
Publicado: (2015)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system
por: OuYang, P-Y, et al.
Publicado: (2013)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
por: Gurzu, Simona, et al.
Publicado: (2019)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
por: Chen, Y-L, et al.
Publicado: (2013)

Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial–mesenchymal transition by inducing 14-3-3γ expression
por: Teo, Z, et al.
Publicado: (2017)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Deng, Yan-Ru, et al.
Publicado: (2016)

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
por: Hu, J. L., et al.
Publicado: (2019)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
por: Mego, M., et al.
Publicado: (2015)

HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells
por: LUO, YIZHOU, et al.
Publicado: (2013)

LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
por: Hou, P, et al.
Publicado: (2014)

An Atypical System for Studying Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Vedagiri, Dhiviya, et al.
Publicado: (2016)

The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
por: Zoheiry, Mona M, et al.
Publicado: (2015)

Epithelial-Mesenchymal Transition Markers in HCV-Associated Hepatocellular Carcinoma: A Multivariate Follow Up Study
por: Helal, Thanaa El-sayed, et al.
Publicado: (2022)

Clinical Significance of Combined Epithelial–Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma
por: Shin, Seung Kak, et al.
Publicado: (2023)

Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts
por: Chen, Z-Y, et al.
Publicado: (2014)

Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial–mesenchymal transition-induced angiogenesis
por: Li, C, et al.
Publicado: (2016)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Zhang, Shidong, et al.
Publicado: (2020)

SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans
por: Zhang, L, et al.
Publicado: (2016)

Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial–mesenchymal transition of cancer cells
por: Lam, C R I, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qa22vl9fi2u378b507k5siuuej